Core Viewpoint - The announcement details the achievement of the first unlock period conditions for the 2024 restricted stock incentive plan, allowing 112 eligible participants to unlock a total of 3.849575 million shares, representing 0.7369% of the company's total share capital [1][12]. Summary by Sections Incentive Plan Overview - The 2024 restricted stock incentive plan was approved in meetings held on July 29 and August 14, 2024, with a total of 116 participants receiving 8.13565 million shares after adjustments [2][6]. - The plan's duration is up to 48 months from the date of stock grant registration [2]. Unlock Conditions - The first unlock period allows for 50% of the granted shares to be unlocked after 12 months, and the remaining 50% after 24 months [2]. - The performance assessment for the unlock conditions is based on the company's financial performance in 2024 and 2025, with specific revenue and profit growth targets set [2][4]. Performance Targets - For the first unlock period, the company must achieve either a 15% revenue growth or a 10% net profit growth compared to 2023 [3][4]. - For the second unlock period, the targets include a 26.5% revenue growth or a 15% net profit growth over the two-year period [4]. Performance Assessment Results - The company reported a revenue of 1,500.4384 million yuan for 2024, achieving a 15.41% growth, and a net profit of 209.8692 million yuan, achieving a 15.35% growth [15]. - The personal performance assessment for the participants resulted in a 100% unlock ratio for 29 individuals, while 12.325 million shares were subject to repurchase due to unmet conditions [16][17]. Approval and Legal Compliance - The board and supervisory committee confirmed that all necessary approvals and legal requirements were met for the unlock conditions to be fulfilled [19][20]. - The legal opinion from Jiangxi Huabang Law Firm affirmed the legitimacy of the unlock conditions and the eligibility of the participants [19][20].

Core Viewpoint - The report outlines the independent financial advisory opinion regarding the first grant of the 2025 restricted stock incentive plan by Shanxi Qianyuan Pharmaceutical Group Co., Ltd, confirming that the necessary approvals and authorizations have been obtained and that the plan complies with relevant regulations [6][10]. Group 1: Incentive Plan Overview - The incentive plan involves granting restricted stocks to employees, which will have a lock-up period and can only be traded after certain conditions are met [2][4]. - The plan includes a total of 915,000 shares, with 795,000 shares (86.89%) allocated to core personnel and 120,000 shares (13.11%) reserved for future grants [9]. Group 2: Approval Process - The necessary approval procedures for the incentive plan have been completed, including the review and approval of relevant proposals by the board and shareholders [4][6]. - The company has publicly disclosed the list of recipients for the first grant, with no objections received during the public notice period [5]. Group 3: Grant Conditions - The grant of restricted stocks is contingent upon meeting specific conditions, including the absence of negative audit opinions and compliance with legal regulations [6][7]. - The board has confirmed that both the company and the recipients meet the necessary conditions for the grant [7]. Group 4: Vesting Schedule - The restricted stocks will be released in three batches over a period of 36 months, with 40% vesting after 12 months, 30% after 24 months, and the remaining 30% after 36 months [7][8]. - During the lock-up period, the stocks cannot be transferred or used as collateral [8]. Group 5: Financial Impact - The company is advised to account for the costs associated with the stock incentive plan in accordance with relevant accounting standards, and shareholders should be aware of potential dilution effects [10].

Core Viewpoint - Shanxi Qianyuan Pharmaceutical Group Co., Ltd. has approved the 2025 Restricted Stock Incentive Plan, granting 7.95 million shares of restricted stock at a price of 5.60 yuan per share to 171 eligible incentive objects on August 8, 2025 [1][11]. Summary by Sections Incentive Plan Overview - The total number of restricted stocks to be granted under the incentive plan does not exceed 9.15 million shares, accounting for 3.68% of the company's total share capital [2]. - The first grant involves 7.95 million shares, which is 86.89% of the total grant amount [10]. - The lock-up periods for the granted restricted stocks are set at 12, 24, and 36 months [2]. Performance Assessment Criteria - The performance assessment for the first grant period requires a net profit growth rate of no less than 25.43% in 2025 compared to 2024 [5]. - For the second grant period in 2026, the required growth rate is 71.04%, and for the third grant period in 2027, it is 133.96% [6][7]. Decision-Making Process - The decision-making process for the incentive plan has been completed, with necessary approvals obtained from the board and the compensation and assessment committee [9][11]. - The plan has been publicly disclosed for 10 days without any objections [9]. Legal and Financial Opinions - Legal opinions confirm that the incentive plan complies with relevant laws and regulations, and the conditions for granting the restricted stocks have been met [12][13]. - The independent financial advisor has also affirmed that the plan's implementation does not harm the interests of the company and its shareholders [12][13]. Financial Impact - The implementation of the restricted stock incentive plan is expected to have a limited impact on the company's financial status and operating results [11][12]. - The funds raised from the stock grant will be used to supplement the company's working capital [12].

证券代码：603276 证券简称：恒兴新材 公告编号：2025-055 江苏恒兴新材料科技股份有限公司 关于向公司 2025 年股权激励计划激励对象 首次授予限制性股票的公告 事会第十六次会议，审议通过了《关于公司<2025 年股权激励计划（草案）>及 其摘要的议案》《关于公司<2025 年股权激励计划实施考核管理办法>的议案》 等议案。公司监事会对本次激励计划的相关事项进行核实并出具了相关核查意见。 了《关于独立董事公开征集投票权的公告》（公告编号：2025-048），根据公司 其他独立董事的委托，独立董事鲍旭锋作为征集人就公司 2025 年第一次临时股 东大会审议的本激励计划相关议案向公司全体股东征集投票权。 年 8 月 1 日。公示期间，公司监事会未收到任何员工对本激励计划拟激励对象提 出的异议，并于 2025 年 8 月 2 日对外披露了《江苏恒兴新材料科技股份有限公 司监事会关于公司 2025 年股权激励计划首次授予部分激励对象名单的核查意见 及公示情况说明》（公告编号：2025-050）。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性 ...

证券代码：688337 证券简称：普源精电 公告编号：2025-035 普源精电科技股份有限公司 关于 2024 年限制性股票激励计划第一类限制性股票 第一个限售期解除限售条件成就的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 本次符合解除限售条件的第一类限制性股票激励对象共计 64 人，可 解除限售的第一类限制性股票数量为 214,721 股，占公司目前股本总额的 ? 本次第一类限制性股票在相关部门办理完解除限售手续后、上市流 通前，公司将发布相关提示性公告，敬请投资者注意。 普源精电科技股份有限公司（以下简称"公司"）于 2025 年 8 月 8 日召开 第二届董事会第二十八次会议和第二届监事会第二十六次会议，审议通过了《关 于 2024 年限制性股票激励计划第一类限制性股票第一个限售期解除限售条件成 就的议案》，公司 2024 年限制性股票激励计划（以下简称"本次激励计划"）第 一类限制性股票第一个解除限售期解除限售条件已成就，共计 64 名符合条件的 激励对象合计可解除限售第一类限制性股 ...

Core Viewpoint - The legal opinion letter from King & Wood Mallesons (Guangzhou) Law Firm confirms that Guangzhou Huali Technology Co., Ltd. has complied with necessary legal procedures for its 2024 stock option and restricted stock incentive plan adjustments and grants [1][14]. Group 1: Approval and Authorization - On September 20, 2024, the company held its second extraordinary general meeting of shareholders, which approved the incentive plan and authorized the board to adjust the exercise price of stock options and restricted stocks as necessary [5][6]. - The board's decisions on August 7, 2025, included adjusting the exercise price of stock options from 15.11 CNY to 14.91 CNY and the grant price of restricted stocks from 9.07 CNY to 8.87 CNY [6][10]. Group 2: Granting Conditions - The granting of stock options and restricted stocks is contingent upon the fulfillment of specific conditions, including the absence of negative audit opinions and compliance with relevant laws and regulations [12][13]. - The company confirmed that the granting conditions were met, and the designated recipients of the incentive plan are eligible under the applicable laws and regulations [12][14]. Group 3: Adjustment Procedures - The adjustment of the exercise price and grant price is in accordance with the provisions outlined in the incentive plan, which allows for adjustments in the event of capital increases, stock dividends, or other corporate actions [8][9]. - The company’s 2024 annual equity distribution plan included a cash dividend of 2.00 CNY per 10 shares, totaling approximately 29.34 million CNY, which triggered the price adjustments [9][10]. Group 4: Legal Compliance - The law firm conducted thorough due diligence and confirmed that all necessary approvals and authorizations for the adjustments and grants have been obtained, ensuring compliance with the relevant regulations [3][14]. - The legal opinion letter serves as a required document for the implementation of the incentive plan and is to be submitted to the Shenzhen Stock Exchange for public announcement [4][5].

Group 1: Company Overview - The company operates in the fine chemical sector, focusing on the research, production, and sales of surfactants and cleaning products, with production bases in Changsha, Shanghai, and Dongguan [2] - Annual production capacity for surfactants exceeds 60,000 tons, while cleaning products have an annual capacity of approximately 25,000 tons [2] Group 2: Pricing and Market Position - The pricing logic for surfactant products is based on "main material costs + other costs + reasonable profit" [2] - The top five manufacturers of anionic surfactants in China account for over 70% of the national production, with the company ranking among the top two in terms of production and sales volume [2] Group 3: Financial Aspects - The share-based payment expense for the year 2024 is projected to be 33.1658 million yuan (pre-tax), while for 2025, it is estimated at 12.8660 million yuan (pre-tax) [3] Group 4: Cost Management and Strategy - Direct materials constitute over 90% of the production costs, and the company employs a pricing strategy that links product sales prices to raw material procurement prices to manage costs effectively [4] - The company aims to enhance its decision-making capabilities regarding market fluctuations and adjust raw material inventory based on market changes to improve profitability [4] Group 5: Strategic Planning - The current strategic plan focuses on strengthening the core business without diversifying into palm oil production or acquisitions, emphasizing product structure optimization and market expansion [5]

Group 1 - The company held its 15th meeting of the third supervisory board on August 4, 2025, with all three supervisors participating in the voting, complying with relevant laws and regulations [1] - The supervisory board approved the proposal to change the registered capital, cancel the supervisory board, and amend the company's articles of association, allowing the audit committee of the board to assume the supervisory board's responsibilities [1][2] - The proposal to change part of the fundraising projects for the company's convertible bonds was also approved, aligning with the company's strategic planning and operational needs [2][3] Group 2 - The company approved a proposal for its subsidiary, Kunshan Guoli Yuantong New Energy Technology Co., Ltd., to implement equity incentives through capital increase, which is expected to enhance internal motivation and align employee interests with those of the company [3] - The voting results for the equity incentive proposal included 2 votes in favor, 0 against, 0 abstentions, and 1 abstention due to conflict of interest [3]

Core Viewpoint - The company is implementing a capital increase for its subsidiary, Kunshan Guoli Yuantong New Energy Technology Co., Ltd., to establish an employee stock ownership plan aimed at enhancing competitiveness and optimizing capital structure [1][2]. Summary by Sections Related Transactions Overview - Kunshan Guoli Yuantong is a subsidiary focused on the R&D, production, and sales of DC contactors. The capital increase aims to improve its competitiveness and establish a long-term incentive mechanism for its management and key employees [1][2]. Details of the Capital Increase - The capital increase is based on the audited net assets of 91.6555 million yuan as of December 31, 2024, with an investment amount of 15 million yuan, resulting in an increase of registered capital by 15 million yuan, corresponding to a 13.6684% equity stake post-increase [2][6]. - Key personnel, including the company's supervisor and a director's relative, will participate in the stock incentive through an employee holding platform [2][5]. Related Parties Information - The employee holding platform, Kunshan Yuanyu Enterprise Management Partnership, is associated with the company through its supervisor, Li Qinghua, and director Huang Hao's relative, Huang Zhiqi [3][4]. Financial Data - As of December 31, 2024, the subsidiary's total assets were 609.7163 million yuan, with total liabilities of 511.3449 million yuan and net assets of 91.5818 million yuan. The operating income for the year was 122.9815 million yuan, with a net profit of 4.1627 million yuan [8][10]. Necessity and Impact of the Related Transactions - The capital increase is deemed necessary to motivate key personnel and enhance the subsidiary's capital structure, which is expected to drive sustainable development [10][11]. Approval Process - The proposal for the capital increase and stock incentive was approved by the independent directors, board of directors, and supervisory board, ensuring compliance with relevant regulations [12].

证券简称：致远互联 证券代码：688369 北京致远互联软件股份有限公司 （草案） 北京致远互联软件股份有限公司 声 明 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本公司所有激励对象承诺，公司因信息披露文件中有虚假记载、误导性陈 述或者重大遗漏，导致不符合授予权益或权益归属安排的，激励对象应当自相 关信息披露文件被确认存在虚假记载、误导性陈述或者重大遗漏后，将由本激 励计划所获得的全部利益返还公司。 特别提示 一、本激励计划系依据《中华人民共和国公司法》《中华人民共和国证券法》 《上海证券交易所科创板股票上市规则》《上市公司股权激励管理办法》《科创 板上市公司自律监管指南第 4 号——股权激励信息披露》等其他有关法律法规、 规范性文件，以及《北京致远互联软件股份有限公司章程》制定。 二、本激励计划采取的激励工具为限制性股票（第二类限制性股票）。股票 来源为北京致远互联软件股份有限公司（以下简称"公司"或"本公司"）从二 级市场回购或/和向激励对象定向发行公司 A 股普通股股票。 符合本激励计划授予条件的激励对象，在满 ...